Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-24 6:07 PM View:  | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 19-Apr-24 | Sale (Planned) | 20,000 | $5.87 | $117,400.00 | (< 1%) 6.01M to 5.99M | |
| 11-Apr-24 6:17 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 09-Apr-24 | Sale (Planned) | 1,900 | $7.00 | $13,304.00 | (< 1%) 6.01M to 6.01M | |
| 21-Mar-24 6:19 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 20-Mar-24 | Payment of Exercise | 2,129 | $6.70 | $14,264.30 | (39%) 5.46K to 3.33K | |
| 21-Mar-24 6:19 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 20-Mar-24 | Option Exercise | 5,464 | -- | -- | 100% 0 to 5.46K | |
| 19-Mar-24 6:25 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 19-Mar-24 | Sale (Planned) | 20,000 | $6.71 | $134,200.00 | (< 1%) 6.03M to 6.01M | |
| 19-Mar-24 6:25 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 18-Mar-24 | Sale (Planned) | 20,000 | $6.77 | $135,400.00 | (< 1%) 6.05M to 6.03M | |
| 13-Mar-24 6:50 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 1,301 | $7.22 | $9,393.22 | (2%) 52.36K to 51.05K | |
| 13-Mar-24 6:39 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 1,912 | $7.22 | $13,804.60 | (5%) 38.08K to 36.17K | |
| 13-Mar-24 6:53 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 478 | $7.22 | $3,451.16 | (8%) 5.79K to 5.32K | |
| 13-Mar-24 6:44 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 4,908 | -- | -- | 5% 94.47K to 99.38K | |
| 13-Mar-24 6:55 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 9,817 | -- | -- | < 1% 6.04M to 6.05M | |
| 13-Mar-24 6:48 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 15,708 | -- | -- | < 1% 5.29M to 5.31M | |
| 13-Mar-24 6:44 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 1,912 | $7.22 | $13,804.60 | (2%) 99.38K to 97.47K | |
| 13-Mar-24 6:55 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 2,911 | $7.22 | $21,017.40 | (< 1%) 6.05M to 6.05M | |
| 13-Mar-24 6:50 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 3,338 | -- | -- | 7% 49.02K to 52.36K | |
| 13-Mar-24 6:39 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 4,908 | -- | -- | 15% 33.17K to 38.08K | |
| 13-Mar-24 6:48 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 4,646 | $7.22 | $33,544.10 | (< 1%) 5.31M to 5.3M | |
| 13-Mar-24 6:53 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 1,227 | -- | -- | 27% 4.57K to 5.79K | |
| 22-Feb-24 5:46 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Option Exercise | 6,758 | -- | -- | < 1% 5.29M to 5.29M | |
| 22-Feb-24 5:34 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Payment of Exercise | 683 | $8.38 | $5,723.54 | (< 1%) 95.15K to 94.47K | |
| 22-Feb-24 5:50 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Payment of Exercise | 588 | $8.38 | $4,927.44 | (< 1%) 6.04M to 6.04M | |
| 22-Feb-24 5:32 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Option Exercise | 790 | -- | -- | 2% 48.54K to 49.33K | |
| 22-Feb-24 5:37 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Option Exercise | 2,016 | -- | -- | 6% 31.94K to 33.96K | |
| 22-Feb-24 5:46 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Payment of Exercise | 2,004 | $8.38 | $16,793.50 | (< 1%) 5.29M to 5.29M | |
| 22-Feb-24 5:49 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Option Exercise | 1,006 | -- | -- | 25% 3.95K to 4.96K | |
| 22-Feb-24 5:32 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Payment of Exercise | 308 | $8.38 | $2,581.04 | (< 1%) 49.33K to 49.02K | |
| 22-Feb-24 5:37 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Payment of Exercise | 786 | $8.38 | $6,586.68 | (2%) 33.96K to 33.17K | |
| 22-Feb-24 5:49 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Payment of Exercise | 392 | $8.38 | $3,284.96 | (8%) 4.96K to 4.57K | |
| 22-Feb-24 5:34 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Option Exercise | 1,752 | -- | -- | 2% 93.4K to 95.15K | |
| 22-Feb-24 5:50 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 20-Feb-24 | Option Exercise | 1,981 | -- | -- | < 1% 6.04M to 6.04M | |
| 27-Dec-23 5:36 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 26-Dec-23 | Sale (Planned) | 3,000 | $9.50 | $28,500.00 | (3%) 96.4K to 93.4K | |
| 21-Dec-23 5:35 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 19-Dec-23 | Sale (Planned) | 20,000 | $9.43 | $188,600.00 | (< 1%) 6.06M to 6.04M | |
| 27-Nov-23 8:53 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 24-Nov-23 | Sale (Planned) | 3,000 | $6.94 | $20,820.00 | (3%) 99.4K to 96.4K | |
| 21-Nov-23 5:59 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 20-Nov-23 | Planned Option Sale | 9,344 | $6.03 | $56,344.30 | (< 1%) 7.78M to 7.77M | |
| 21-Nov-23 5:59 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 20-Nov-23 | Sale (Planned) | 10,656 | $6.03 | $64,255.70 | (< 1%) 7.77M to 7.76M | |
| 21-Nov-23 5:52 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Option Exercise | 5,433 | -- | -- | 6% 96.08K to 101.52K | |
| 21-Nov-23 5:56 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Payment of Exercise | 1,928 | $5.98 | $11,529.40 | (33%) 5.88K to 3.95K | |
| 21-Nov-23 5:59 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Payment of Exercise | 3,203 | $5.98 | $19,153.90 | (< 1%) 7.79M to 7.78M | |
| 21-Nov-23 5:54 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Option Exercise | 3,293 | -- | -- | 7% 46.53K to 49.82K | |
| 21-Nov-23 5:46 PM View: | Barnett Valerie General Counsel | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Payment of Exercise | 2,220 | $5.98 | $13,275.60 | (6%) 34.16K to 31.94K | |
| 21-Nov-23 5:48 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Payment of Exercise | 6,240 | $5.98 | $37,315.20 | (< 1%) 5.29M to 5.29M | |
| 21-Nov-23 5:56 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Option Exercise | 4,947 | -- | -- | 529% 0.94K to 5.88K | |
| 21-Nov-23 5:46 PM View: | Barnett Valerie General Counsel | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Option Exercise | 5,697 | -- | -- | 20% 28.47K to 34.16K | |
| 21-Nov-23 5:48 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Option Exercise | 18,539 | -- | -- | < 1% 5.28M to 5.29M | |
| 21-Nov-23 5:52 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Payment of Exercise | 2,117 | $5.98 | $12,659.70 | (2%) 101.52K to 99.4K | |
| 21-Nov-23 5:59 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Option Exercise | 9,344 | -- | -- | < 1% 7.78M to 7.79M | |
| 21-Nov-23 5:54 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 18-Nov-23 | Payment of Exercise | 1,283 | $5.98 | $7,672.34 | (3%) 49.82K to 48.54K | |
| 27-Nov-23 8:48 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 14-Nov-23 | Gift | 1,700,000 | -- | -- | (22%) 7.76M to 6.06M | |
| 08-Nov-23 6:03 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 07-Nov-23 | Sale (Planned) | 20,000 | $4.34 | $86,800.00 | (< 1%) 5.3M to 5.28M | |
| 25-Oct-23 6:29 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 24-Oct-23 | Sale (Planned) | 3,000 | $4.68 | $14,040.00 | (3%) 99.08K to 96.08K |
